Core Scientific (NASDAQ:CORZ) Stock: Insider Todd Duchene Sells 10,000 Shares

Core Scientific, Inc. (NASDAQ:CORZ) insider Todd Duchene sold 10,000 shares of Core Scientific stock in a transaction dated Monday, October 12th. The stock was sold at an average price of $15.12, for a total value of $151,200.00. Following the completion of the sale, the insider owned 1,159,668 shares in the company, valued at approximately $17,534,180.16. The trade was a 0.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Core Scientific Trading Up 7.0%

NASDAQ:CORZ opened at $14.45 on Friday. Core Scientific, Inc. has a 12 month low of $12.31 and a 12 month high of $30.46. The stock has a 50 day moving average of $17.45 and a two-hundred day moving average of $21.05. The firm has a market cap of $4.64 billion, a P/E ratio of -3.27 and a beta of 5.49.

Core Scientific (NASDAQ:CORZ) last released its earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The firm had revenue of $164.20 million during the quarter, compared to analyst estimates of $144.83 million. On average, research analysts forecast that Core Scientific, Inc. will post -1.36 earnings per share for the current year.

Institutional Trading of Core Scientific

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Parkside Financial Bank & Trust boosted its position in shares of Core Scientific by 1,371.3% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,177 shares of the company’s stock valued at $30,000 after acquiring an additional 1,097 shares during the last quarter. CoreCap Advisors LLC purchased a new stake in shares of Core Scientific in the second quarter valued at about $36,000. Rakuten Securities Inc. purchased a new stake in shares of Core Scientific in the second quarter valued at about $47,000. PNC Financial Services Group Inc. increased its position in Core Scientific by 41.3% during the first quarter. PNC Financial Services Group Inc. now owns 4,396 shares of the company’s stock worth $66,000 after purchasing an additional 1,285 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in Core Scientific by 34.5% during the second quarter. GAMMA Investing LLC now owns 3,049 shares of the company’s stock worth $78,000 after purchasing an additional 782 shares during the last quarter.

Wall Street Analysts Forecast Growth

CORZ has been the subject of several recent research reports. Rothschild & Co Redburn began coverage on Core Scientific in a research note on Monday, September 21st. They issued a “neutral” rating and a $16.00 price objective for the company. Capital One Financial set a $33.00 price objective on Core Scientific in a report on Thursday, July 30th. Keefe, Bruyette & Woods raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $25.00 to $28.00 in a research note on Thursday, July 30th. BTIG Research reaffirmed a “buy” rating and set a $38.00 target price on shares of Core Scientific in a research note on Thursday. Finally, Needham & Company LLC upped their target price on shares of Core Scientific from $29.00 to $35.00 and gave the stock a “buy” rating in a report on Wednesday, July 29th. Two research analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $31.36.

Core Scientific News Roundup

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analyst support strengthened: Canaccord Genuity reaffirmed a “Buy” rating with a $36 price target, while BTIG Research maintained its “Buy” rating with a $38 target. Cantor Fitzgerald also reaffirmed an “Overweight” rating and set a $39 target. These targets imply substantial upside from recent trading levels. Canaccord Genuity Core Scientific rating
• Positive Sentiment: Needham maintained its $35 target: The firm reiterated its bullish valuation even as it noted credit pressure facing Core Scientific’s tenant, CoreWeave. Continued analyst confidence supports the investment case for CORZ’s data-center and AI infrastructure expansion. Needham reiterates Core Scientific price target
• Neutral Sentiment: Upcoming earnings event: Core Scientific will release third-quarter fiscal 2026 results before the market opens on November 5 and hold a conference call at 8:30 a.m. Eastern time. Investors will look for updates on revenue, profitability, customer demand and AI data-center capacity. Core Scientific third-quarter 2026 earnings announcement
• Negative Sentiment: Insider sale adds a modest cautionary signal: Director Todd DuChene sold 10,000 shares for approximately $151,200, reducing his direct ownership by 0.85%. He still retains a substantial position, so the transaction may have limited significance, but insider selling can weigh on sentiment.
• Negative Sentiment: Tenant credit risk remains a concern: Needham’s commentary indicates that financial pressure at CoreWeave could create uncertainty for Core Scientific because of the tenant relationship, potentially affecting contract execution or investor confidence despite the maintained price target.

Core Scientific Company Profile

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.